3 research outputs found
Self-reported risk factors for HCV transmission in the anti-HCV positive population at the Berlin study site.
<p>IVDU, intravenous drug-use.</p><p>Multiple responses were possible. Percentages are given in relation to all anti-HCV positive patients (n = 535).</p
Distribution of anti-HCV and HCV-RNA status for each of the two study sites alone and all patients combined.
<p>Serum samples for HCV-RNA analysis were available from 685 out of 757 anti-HCV positive patients.</p
Patient characteristics.
a<p>ULN = upper limit of normal; <sup>b</sup>of 42 HCV-RNA negative patients, 3 were still on antiviral treatment at the time of study inclusion.</p